Family 2 Incretin peptides (appetite and insulin pathways): Semaglutide is a single GLP-1 receptor agonist
As a result Novo Nordisk and the National Institutes of Health funded a randomised, double-blind, controlled trial to look at the issue
Having toast, rice, bananas, applesauce, soup, oatmeal, and crackers in the house can make a huge difference
By stimulating the GLP-1 and GIP pathways, as well as glucagon receptors, Retatrutide enables the study of integrated metabolic responses rather than isolated receptor activities
10.1016/j.oooo.2022.08.004 5 AlrawiS
Retatrutide is not yet available in the UK, with phase III trial results expected in 2026